Shipra Aggarwal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shipra Aggarwal has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- A Gupta
Department of Anaesthesiology and Intensive Care, Vardhman Mahavir Medical College and Safdarjung Hospital, India
1 shared publication - A Luna
Department of Anaesthesiology and Intensive Care, Vardhman Mahavir Medical College and Safdarjung Hospital, India
1 shared publication - Divya Rani1 shared publication
- Manish Verma
Department of Otolaryngology and Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi, India
1 shared publication - Meenakshi Verma1 shared publication
- Mridula Pawar
Department of Anaesthesia and Intensive Care, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
1 shared publication
Latest Publications
- Open Access
- 22 January 2025
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Anaesthesiology
- Vol. 33 (01) , 107-112
The Effect of Opioid-Free Anaesthesia in an Apert Syndrome Child: A Case Series
Apert syndrome is an autosomal dominant inherited syndrome that presents with craniosynostosis, mid-face hypoplasia, and symmetrical syndactyly of limbs. These patients undergo different types of surgery and are challenging to the anaesthesiologist in terms of a difficult airway, causing difficulty in bag-mask ventilation and an increased incidence of postoperative airway obstruction. Apert syndrome is a congenital anomaly that is associated with a difficult airway, so we avoid opioids to decrease complications like sedation and respiratory depression and use dexmedetomidine to facilitate early postoperative recovery. We report the perioperative management of a case series of six patients with Apert syndrome with opioid-free anaesthesia.
- 22 January 2025
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Anaesthesiology
- Vol. 33 (01) , 107-112
Open AccessThe Effect of Opioid-Free Anaesthesia in an Apert Syndrome Child: A Case Series
Apert syndrome is an autosomal dominant inherited syndrome that presents with craniosynostosis, mid-face hypoplasia, and symmetrical syndactyly of limbs. These patients undergo different types of surgery and are challenging to the anaesthesiologist in terms of a difficult airway, causing difficulty in bag-mask ventilation and an increased incidence of postoperative airway obstruction. Apert syndrome is a congenital anomaly that is associated with a difficult airway, so we avoid opioids to decrease complications like sedation and respiratory depression and use dexmedetomidine to facilitate early postoperative recovery. We report the perioperative management of a case series of six patients with Apert syndrome with opioid-free anaesthesia.
- Open Access
- 1 September 2022
- Published by AOSIS in Southern African Journal of Anaesthesia and Analgesia
- Vol. 28 (4) , 151-155
Comparison of a ketamine-propofol combination and etomidate for anaesthesia induction on haemodynamic parameters in patients undergoing coronary artery bypass grafting
Objective: To compare the haemodynamic response of both a ketamine-propofol (ketofol) combination and etomidate for anaesthesia induction in patients undergoing coronary artery bypass grafting (CABG). ...
- 1 September 2022
- Published by AOSIS in Southern African Journal of Anaesthesia and Analgesia
- Vol. 28 (4) , 151-155
Open AccessComparison of a ketamine-propofol combination and etomidate for anaesthesia induction on haemodynamic parameters in patients undergoing coronary artery bypass grafting
Objective: To compare the haemodynamic response of both a ketamine-propofol (ketofol) combination and etomidate for anaesthesia induction in patients undergoing coronary artery bypass grafting (CABG). ...
- Open Access
- 1 August 2018
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 71 (4) , 305-310
Comparison of priming versus slow injection for reducing etomidate-induced myoclonus: a randomized controlled study
Background: Etomidate injection is often associated with myoclonus. Etomidate injection technique influences the incidence of myoclonus. This study was designed to clarify which of the two injection techniques-slow injection or priming with etomidate-is more effective in reducing myoclonus. Methods: This prospective randomized controlled study was conducted on 189 surgical patients allocated to three study groups. Control group (Group C, n = 63) received 0.3 mg/kg etomidate (induction dose) over 20 s. Priming group (Group P, n = 63) received pretreatment with 0.03 mg/kg etomidate, followed after 1 min by an etomidate induction dose over 20 s. Slow injection group (Group S, n = 63) received etomidate (2 mg/ml) induction dose over 2 min. The patients were observed for occurrence and severity of myoclonus for 3 min from the start of injection of the induction dose. Results: The incidence of myoclonus in Group P (38/63 [60.3%], 95% CI: 48.0-71.5) was significantly lower than in Group C (53/63 [84.1%], 95% CI: 72.9-91.3, P = 0.003) and Group S (49/63 [77.8%], 95% CI: 66.0-86.4, P = 0.034). Myoclonus of moderate or severe grade occurred in significantly more patients in Group C (68.3%) than in Group P (36.5%, P < 0.001) and Group S (50.8%, P = 0.046), but the difference between Groups P and S was not significant (P = 0.106). Conclusions: Priming is more effective than slow injection in reducing the incidence of myoclonus, but their effects on the severity of myoclonus are comparable.
- 1 August 2018
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 71 (4) , 305-310
Open AccessComparison of priming versus slow injection for reducing etomidate-induced myoclonus: a randomized controlled study
Background: Etomidate injection is often associated with myoclonus. Etomidate injection technique influences the incidence of myoclonus. This study was designed to clarify which of the two injection techniques-slow injection or priming with etomidate-is more effective in reducing myoclonus. Methods: This prospective randomized controlled study was conducted on 189 surgical patients allocated to three study groups. Control group (Group C, n = 63) received 0.3 mg/kg etomidate (induction dose) over 20 s. Priming group (Group P, n = 63) received pretreatment with 0.03 mg/kg etomidate, followed after 1 min by an etomidate induction dose over 20 s. Slow injection group (Group S, n = 63) received etomidate (2 mg/ml) induction dose over 2 min. The patients were observed for occurrence and severity of myoclonus for 3 min from the start of injection of the induction dose. Results: The incidence of myoclonus in Group P (38/63 [60.3%], 95% CI: 48.0-71.5) was significantly lower than in Group C (53/63 [84.1%], 95% CI: 72.9-91.3, P = 0.003) and Group S (49/63 [77.8%], 95% CI: 66.0-86.4, P = 0.034). Myoclonus of moderate or severe grade occurred in significantly more patients in Group C (68.3%) than in Group P (36.5%, P < 0.001) and Group S (50.8%, P = 0.046), but the difference between Groups P and S was not significant (P = 0.106). Conclusions: Priming is more effective than slow injection in reducing the incidence of myoclonus, but their effects on the severity of myoclonus are comparable.